[en] The pathogenesis of chronic, verrucous varicella-zoster virus (VZV) cutaneous lesions in human immunodeficiency virus (HIV)-infected persons is unknown. It has been hypothesized that these lesions are due to an altered pattern of virus gene expression. Immediate early and late (L) gene expression in five chronic verrucous VZV lesions, four full-blown herpes zoster vesicular lesions in HIV-infected persons, and eight vesicular herpes zoster lesions in immunocompetent individuals was semiquantitatively assessed immunohistochemically using specific antibodies to the IE63, gE (L), and gB (L) proteins. All patients had evidence of IE63 expression in keratinocytes; however, gE expression was either weak or absent in keratinocytes of three verrucous lesions, and gB was either weak or absent in two. These results suggest that chronic VZV skin lesions are associated with diminished gE and gB expression. It is inferred that the VZV behavior in keratinocytes may vary from a latency-like state to a fully developed, productive infection.
Disciplines :
Immunology & infectious disease
Author, co-author :
Nikkels, Arjen ; Université de Liège - ULiège > Dermatologie
Rentier, Bernard ; Université de Liège - ULiège > Services administratifs généraux > Recteur - GIGA-R : Virologie - Immunologie
Pierard, Gérald ; Université de Liège - ULiège > Dermatopathologie
Language :
English
Title :
Chronic varicella-zoster virus skin lesions in patients with human immunodeficiency virus are related to decreased expression of gE and gB
Leboit PE, Limova M, Benedict Yen TS, Palefsky JM, White CR, Berger TG. Chronic verrucous varicella-zoster virus infection in patients with the acquired immunodeficiency syndromes (AIDS). Am J Dermatopathol 1992;14:1-7.
Smith KJ, Skelton HG, Frissman DM, Angritt P. Verrucous lesions secondary to DNA viruses in patients infected with the human immunodeficiency virus in association with increased factor XIII-a-positive dermal dendritic cells. J Am Acad Dermatol 1992;27:943-50.
Grossman MC, Grossman ME. Chronic hyperkeratotic herpes zoster and human immunodeficiency virus infection. J Am Acad Dermatol 1993;28:306-8.
Lokke-Jensen B, Weismann K, Mathiesen L, Klem-Thomsen H. Atypical varicella-zoster infection in AIDS. Acta Derm Venereol 1993;73:123-5.
Boivin G, Edelman CK, Pedneault L, Talarico CL, Biron KK, Balfour HH. Phenotypic and genotypic characterization of acyclovir-resistant varicella zoster viruses isolated from persons with AIDS. J Infect Dis 1994;170:68-75.
Tronnier M, Plettenberg A, Meigel WN, Wolff HH. Recurrent verrucous herpes zoster in an HIV patient. Demonstration of the virus by immunofluorescence and electron microscopy. Eur J Dermatol 1994;4:604-7.
Vaughan Jones SA, McGibbon DH, Bradbeer CS. Chronic verrucous varicella-zoster infection in a patient with AIDS. Clin Exp Dermatol 1994;19:327-9.
Nikkels AF, Debrus S, Sadzot-Delvaux C, Piette J, Rentier B, Piérard GE. Immunohistochemical identification of varicella zoster virus gene 63-encoded protein (IE63) and late (gE) protein on smears and cutaneous biopsies: implications for diagnostic use. J Med Virol 1995;47:342-7.
Debrus S, Sadzot-Delvaux C, Nikkels AF, Piette J, Rentier B. Varicella zoster virus gene 63 encodes an immediate early protein that is abundantly expressed during latency. J Virol 1995;69:3240-5.
Sadzot-Delvaux C, Debrus S, Nikkels AF, Piette J, Rentier B. Varicella-zoster virus latency in the adult rat is a useful model for human latent infection. Neurology 1995;45(suppl 8):18-20.
Mahalingam R, Wellish M, Cohrs R, et al. Expression of protein encoded by varicella zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci USA 1996;93:2122-4.
Nikkels AF, Delvenne P, Debrus S, et al. Distribution of varicella-zoster virus gpI and gpII and corresponding genome sequences in the skin. J Med Virol 1995;46:91-6.
Nikkels AF, Debrus S, Sadzot-Delvaux C, Piette J, Rentier B, Piérard GE. Localization of varicella-zoster virus nucleic acids and proteins in human skin. Neurology 1995;45(suppl 8):47-9.
